Hartland & Co. LLC grew its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 12.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,925 shares of the medical research company’s stock after acquiring an additional 320 shares during the period. Hartland & Co. LLC’s holdings in Thermo Fisher Scientific were worth $510,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. BB&T Securities LLC boosted its holdings in shares of Thermo Fisher Scientific by 4.4% in the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after acquiring an additional 3,819 shares during the last quarter. Toronto Dominion Bank boosted its holdings in Thermo Fisher Scientific by 53.5% during the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock worth $16,450,000 after buying an additional 37,307 shares in the last quarter. Mitchell Capital Management Co. boosted its holdings in Thermo Fisher Scientific by 40.3% during the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after buying an additional 12,910 shares in the last quarter. IBM Retirement Fund boosted its holdings in Thermo Fisher Scientific by 117.7% during the second quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock worth $1,860,000 after buying an additional 5,157 shares in the last quarter. Finally, Cornerstone Investment Partners LLC boosted its holdings in Thermo Fisher Scientific by 41.7% during the second quarter. Cornerstone Investment Partners LLC now owns 421,541 shares of the medical research company’s stock worth $73,546,000 after buying an additional 123,954 shares in the last quarter. 83.36% of the stock is currently owned by institutional investors and hedge funds.

TMO has been the topic of a number of recent analyst reports. Bank of America Corporation reissued a “buy” rating and set a $210.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Citigroup Inc. reissued a “buy” rating and set a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Finally, Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Saturday, June 10th. One equities research analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $195.33.

In related news, Director Jim P. Manzi sold 11,318 shares of the business’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $172.94, for a total value of $1,957,334.92. Following the sale, the director now directly owns 38,757 shares in the company, valued at approximately $6,702,635.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jim P. Manzi sold 1,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $175.20, for a total transaction of $175,200.00. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock worth $9,302,112 over the last 90 days. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 187.32 on Tuesday. The stock has a market capitalization of $73.08 billion, a P/E ratio of 32.63 and a beta of 1.05. The firm’s 50-day moving average is $181.07 and its 200 day moving average is $171.15. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business’s revenue was up 10.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.03 EPS. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: “Hartland & Co. LLC Acquires 320 Shares of Thermo Fisher Scientific Inc (TMO)” was first reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.watchlistnews.com/hartland-co-llc-acquires-320-shares-of-thermo-fisher-scientific-inc-tmo/1588228.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.